Using multiple omics profiling of HCC patients, we classified tumors by immune activity and discovered significant metabolic and immune-related genes (AGXT2, DPYS, and TNFSF8) whose expression is epigenetically regulated. Here, DPYS is linked to hepatocellular carcinoma.